Oral vs topical hyaluronic acid: what are the differences?
In brief. “Hyaluronic acid” can refer to very different uses. Topically, it is applied to the skin surface in a serum or cream; orally, it is ingested as a supplement; by injection, it is used in a medical or aesthetic procedure with a completely different logic. Results from one route should not be transferred to another. For an oral supplement, the most relevant evidence comes from human trials using the ingredient, dose and duration closest to the product being assessed.
Evidence level for this page: reviews and published trials on oral or topical hyaluronic acid; for Eclo, the study most directly transferable to the ingredient used is the randomized, double-blind, placebo-controlled trial of ExceptionHYAL® Star at 200 mg/day for 28 days.
What is hyaluronic acid?
Hyaluronic acid, or hyaluronan, is a glycosaminoglycan naturally present in many tissues, including skin. Its strong affinity for water and interactions with the extracellular matrix contribute to the hydrated environment and viscoelastic properties of tissues.
This shared chemical identity does not make all forms of hyaluronic acid interchangeable. Molecular weight, source, purity, formulation and route of administration change how a product is used and the scientific question a study answers.
Oral, topical and injectable: three different questions
| Route | Where does exposure begin? | Relevant type of evidence | Common error |
|---|---|---|---|
| Topical | Skin surface | Formulation, hydration, tolerability and penetration studies depending on the product | Assuming all HA penetrates deeply into the dermis |
| Oral | Digestive tract | Supplementation trials with an identified ingredient and dose | Imagining the ingested molecule directly “fills” the skin |
| Injectable | Tissue targeted by injection | Data specific to the injectable product and procedure | Using injectable results as evidence for a serum or supplement |
What can topical hyaluronic acid do?
In skincare, hyaluronic acid is used mainly for its hydrophilic and film-forming properties. A topical formulation can improve superficial hydration and the feeling of suppleness. Molecular weight and vehicle influence its behavior at the skin surface and its penetration.
Marketing phrases such as “reaches the dermis” deserve caution: skin penetration depends on molecular weight, formulation and the methods used to measure it. Data obtained with one particular system should not be generalized to every serum containing hyaluronic acid.
What does research say about oral hyaluronic acid?
The literature includes several randomized controlled trials. A meta-analysis published in 2025 pooled seven randomized clinical trials of oral hyaluronic-acid supplementation. In the authors’ combined analyses, hydration, elasticity and wrinkle depth showed statistically significant improvements, while some other endpoints — including firmness, wrinkle volume and TEWL — did not show a significant difference.
The authors also highlighted limitations in the evidence base: a small number of studies, modest sample sizes and heterogeneous protocols. A meta-analysis broadens the overall view; it does not mean that every raw material, molecular-weight profile or dose produces the same effect.
Why is the ExceptionHYAL® Star study particularly relevant to Eclo?
ExceptionHYAL® Star is the raw material used by Eclo. The 2021 published trial included 60 women with mild to moderate signs of skin ageing, randomized double-blind to 200 mg/day of the ingredient or placebo for 28 days. The authors assessed instrumental skin parameters together with a self-evaluation questionnaire.
This match in identity and dose strengthens relevance: for an Eclo product providing 200 mg of this ingredient, the study is more directly informative than a trial of a different hyaluronic acid at another dose. Even then, it remains an ingredient study, not a study of a finished Eclo formula when other components are combined with it.
Can 200 mg orally be compared with a serum expressed as a percentage?
No. The units and routes do not describe the same exposure. A capsule expressed in milligrams describes an ingested amount. A serum expressed as a percentage describes a concentration in a formulation applied locally. Comparing the numbers without considering route, vehicle, amount applied and biological fate is not meaningful.
Does molecular weight matter?
Yes, but avoid the simplistic rule “smaller is always better”. Molecular weight influences physical properties, diffusion and biological interactions. Topically, it can affect surface behavior and penetration; orally, digestion and metabolism make the question different. A study on a mixture of molecular weights or a proprietary raw material should remain attached to that material.
Is oral hyaluronic acid “better” than topical?
The question is poorly framed. The two routes serve different uses. A topical acts in the context of skincare applied directly to the skin; an oral supplement is systemic supplementation assessed over time. They can be used in the same routine, but the literature does not justify a universal hierarchy of “oral > topical”.
What about injections?
Hyaluronic-acid injections involve injectable products and procedures, often using cross-linked materials deposited directly into a targeted tissue. Their benefits, risks and regulation must be assessed in that context. They are not evidence for a food supplement or topical cosmetic.
How should a hyaluronic-acid claim be read?
- Identify the route: oral, topical or injectable.
- Identify the raw material and, where available, molecular weight or its distribution.
- Check the dose or concentration studied.
- Check the comparator, duration and population.
- Look at the endpoints actually measured: hydration, elasticity, wrinkles, TEWL, etc.
- Do not transfer results from one raw material or route to another without justification.
What we know — and what it does not allow us to conclude
- Published studies: several human trials and a recent meta-analysis have investigated oral hyaluronic acid.
- Published study on the Eclo ingredient: ExceptionHYAL® Star was studied at 200 mg/day in a randomized controlled trial.
- Topical: hyaluronic acid can contribute to the hydration performance of a skincare product, but its behavior depends strongly on formulation.
- Do not extrapolate: an injectable result proves nothing about an oral supplement.
- Do not extrapolate: a study on one specific oral ingredient is not a study of the finished Eclo product.
Frequently asked questions
Can oral and topical hyaluronic acid be used in the same routine?
Yes, they are different routes. Using them together does not automatically create a demonstrated additive effect; a study of the combination would be needed to prove that.
Is 200 mg orally “more” than a 1% serum?
The comparison is not meaningful. 200 mg describes an ingested dose; 1% a concentration in a topical formula. Exposure and biological fate differ.
Is low molecular weight always superior?
No. Molecular weight influences HA properties, but the effect also depends on route, vehicle, molecular-weight distribution and the protocol studied.
Do injection studies prove capsules work?
No. An injection deposits a product locally in tissue; oral supplementation undergoes digestion, absorption and metabolism. They are different interventions.
Sources
- 2025 meta-analysis — oral hyaluronic-acid supplementation and skin parameters
- Michelotti et al., 2021 — randomized, double-blind, placebo-controlled trial, 200 mg/day for 28 days
- Review — topical hyaluronic acid and skin formulations
- Clinical trial — oral hyaluronic acid and skin parameters
Read next
ExceptionHYAL® Star dossier · Skin extracellular matrix · Skin barrier and TEWL · Understanding doses · Hyaluronic Acid 200 mg · Ressource™
Method note: Eclo distinguishes route of administration and the identity of the ingredient studied. Data from a serum, injectable or different hyaluronic acid are not presented as though they were a study of Eclo’s oral formula.
Last scientific review: 26 August 2026.